Drug intelligence / Profile preview

torsemide + spironolactone

Development stage
Unknown
Lead developer
Sarfez Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

**Torsemide + spironolactone** is a fixed-dose combination of two diuretics used primarily to manage edema (fluid retention) and hypertension, especially in patients with heart failure, liver cirrhosis, or kidney disorders[1][3][5][7]. Torsemide is a loop diuretic that works by inhibiting sodium reabsorption in the thick ascending limb of the loop of Henle, resulting in increased urine output and reduced fluid overload. Spironolactone is a potassium-sparing diuretic and a mineralocorticoid receptor antagonist, blocking the action of aldosterone and promoting sodium and water excretion while conserving potassium[1][4][6][8]. The combination provides synergistic diuretic effects while mitigating the risk of hypokalemia typically caused by loop diuretics alone. It is indicated for the treatment of edema due to heart failure, liver cirrhosis, chronic kidney disease, and for hypertension when single diuretic therapy is insufficient[1][3][5][7].

Brand names
TEROMIDE PLUS 10TEROMIDE PLUS LS
Other names
spironolactone + torsemide
02

Targets

MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on torsemide + spironolactone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on torsemide + spironolactone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call